Fuzhisan, a Chinese herbal medicine, inhibits beta-amyloid-induced neurotoxicity and tau phosphorylation through calpain/Cdk5 pathway in cultured cortical neurons.
It has been shown that β-amyloid (Aβ) induced hyperphosphorylation of tau is implicated in the pathogenesis of Alzheimer's disease (AD), and deregulation of cyclin-dependent kinase 5 (Cdk5) activity is involved in the abnormal tau phosphorylation. The cleavage of neuron-specific Cdk5 activator, p35, to p25, mediated by calpain and calcium, deregulates Cdk5 activity and promotes neurodegeneration. Fuzhisan (FZS), a Chinese herbal complex prescription that has been used for the treatment of AD for over 15 years, is known to enhance the cognitive ability in AD patients. In this study, we investigated the neuroprotective effects and potential molecular mechanisms of FZS against Aβ(25-35)-induced toxicity in cultured cortical neurons. We revealed that FZS attenuated Aβ(25-35)-induced neurotoxicity in a dose-dependent manner. FZS inhibited Aβ(25-35)-induced activation of Cdk5 and decreased tau hyperphosphorylation although it did not directly inhibit Cdk5. In addition, FZS also blocked Aβ(25-35)-induced calcium influx, calpain activation and decreased cleavage of p35 to p25.
Department of Neurology, First Affiliated Hospital, Harbin Medical University, 150001 Harbin, China.
Zhaoxu
Z
Zhang
Ruiping
R
Zhao
Ying
Y
Tang
Shirong
S
Wen
Desheng
D
Wang
Jiping
J
Qi
D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors* / Q000502:physiology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002154:Calpain / Q000378:metabolism*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D051360:Cyclin-Dependent Kinase 5 / Q000378:metabolism*; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D004789:Enzyme Activation; D010766:Phosphorylation; D051381:Rats; D017208:Rats, Wistar; D016875:tau Proteins / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D004365:Drugs, Chinese Herbal; C543479:fuzhisan; D016875:tau Proteins; D051360:Cyclin-Dependent Kinase 5; C495907:Cdk5 protein, rat; D002154:Calpain; D002118:Calcium
J Neurochem. 2004 Jan;88(2):349-58
14690523
J Neurochem. 1997 Sep;69(3):978-85
9282919
J Neurochem. 2003 Jan;84(2):347-62
12558997
Biochem Biophys Res Commun. 2002 Nov 15;298(5):693-8
12419309
Neuron. 2003 Oct 30;40(3):471-83
14642273
Curr Opin Neurobiol. 2004 Jun;14(3):390-4
15194121
Ann N Y Acad Sci. 1993 Sep 24;695:209-16
7694533
Science. 1991 Feb 8;251(4994):675-8
1899488
Nat Rev Mol Cell Biol. 2001 Oct;2(10):749-59
11584302
Exp Cell Res. 2001 Apr 1;264(2):266-74
11262183
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6364-9
11959919
Neuropharmacology. 2009 Feb;56(2):422-8
18948125
Neuron. 1995 Apr;14(4):879-88
7718249
Neuron. 1988 Nov;1(9):827-34
2483105
J Neurochem. 2007 Jun;101(5):1303-15
17298384
Neuroscience. 2009 Jul 21;161(4):978-87
19362124
J Biol Chem. 2000 May 26;275(21):15733-40
10747907
Neuron. 2003 May 22;38(4):555-65
12765608
Life Sci. 2009 Feb 27;84(9-10):257-62
19101570
J Neurosci Res. 2008 Sep;86(12):2685-95
18512759
Neurochem Int. 2008 Mar-Apr;52(4-5):621-33
18035450
J Neuropathol Exp Neurol. 1994 Sep;53(5):438-47
8083687
EMBO J. 2005 Jan 12;24(1):209-20
15592431
Nature. 2000 May 18;405(6784):360-4
10830966
Neurosci Lett. 2004 May 6;361(1-3):47-51
15135890
Life Sci. 2010 Mar 27;86(13-14):532-7
20153752
Exp Gerontol. 2008 Sep;43(9):853-8
18606218
FEBS Lett. 1999 Oct 15;459(3):421-6
10526177
Aging Cell. 2010 Feb;9(1):64-77
19895631
Brain Res. 2008 Mar 20;1200:99-106
18289510
Neurosci Res. 1999 May;34(1):21-9
10413323
Nature. 1999 Dec 9;402(6762):615-22
10604467
J Neuropathol Exp Neurol. 2001 Apr;60(4):357-68
11305871
Arch Pharm Res. 2009 Jul;32(7):989-96
19641879
Brain Res. 2008 Jan 10;1188:254-62
18031715
Cell Mol Neurobiol. 2008 May;28(3):351-69
18183483
Acta Neuropathol. 2002 Jan;103(1):26-35
11837744